940. Deputy Michael Collins asked the Minister for Health the reason the HSE has not yet approved funding for the drug dupixent (dupilumab) for adults with eosinophilic oesophagitis; the stage the pricing and assessment process is currently at; when a decision is expected; and if she will make a statement on the matter. [45320/26]

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.